1. Outcomes and associated risk factors for aortic valve replacement in 160 children;Karamlou;Circulation,2005
2. Schmidt P. A new paradigm for obtaining marketing approval for pediatric sized prosthetic heart valves: engineering breakout session summary presentation. Pediatric Heart Valve Workshop; January 12, 2010; Washington, DC.
3. Vidmar S. A new paradigm for obtaining marketing approval for pediatric sized prosthetic heart valves: clinical breakout session summary presentation. Pediatric Heart Valve Workshop; January 12, 2010; Washington, DC.
4. US Food and Drug Administration, Center for Devices and Radiological Health. Pediatric expertise for advisory Panels: guidance for industry and FDA staff. Silver Spring, MD: US Food and Drug Administration; 2003.
5. International Organization of Standardization. Cardiovascular implants—cardiac valve prostheses. ISO 5840:2005.